Salute e Benessere
Medicilon Appoints Dr. Lilly Xu as Chief Technology Officer
"We are thrilled to welcome Dr. Xu during this pivotal time in Medicilon's growth," said Dr. Chunlin Chen , Founder and CEO of Medicilon. "Her extensive expertise and global perspective align with our vision of driving innovation and advancing our international presence."
Dr. Xu added, "I'm honored to join Medicilon's forward-thinking team. I look forward to contributing to platform innovation, accelerating the transition of research into clinical breakthroughs, and achieving milestones that will benefit our global clients and their patients."
Medicilon continues to expand its advanced research platforms, including nucleic acids, ADCs, PROTACs, antibodies, and cell and gene therapies, reinforcing its position as a leader in preclinical drug development.
Website: https://www.medicilon.com/
View original content: https://www.prnewswire.co.uk/news-releases/medicilon-appoints-dr-lilly-xu-as-chief-technology-officer-302337085.html